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Abstract 
Purpose: To investigate the cytotoxic and apoptotic activities of Ficus pseudopalma (FP) Blanco leaf 
extracts against normal human FSE cells and human prostate PRST2 cancer cell line. 
Methods: FP leaves were extracted with 95 % ethanol, and partitioned with chloroform, ethylacetate, 
and water. The presence of terpenoid lupeol and flavonoid quercetin was determined through high 
performance liquid chromatography (HPLC). The cytotoxic and apoptotic effects of different 
concentrations of FP extracts on PRST2 cells and on non-cancerous human foreskin surface 
epithelial (hFSE) cells were determined by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium 
bromide (MTT) assay, tryphan blue exclusion assay, Live/Dead viability assay and terminal 
deoxynucleotidyl transferase dUTP nick end labelling  (TUNEL)  assay.  
Results:  Ethylacetate, chloroform, and crude ethanol extracts were significantly cytotoxic to PRST2 
cell lines (p < 0.001)  in a concentration-dependent manner with a 50 % cell growth inhibitory 
concentration of 4.16, 4.83 and 44.53 µg/mL, respectively.  A significant decrease in the viability of 
PRST2-treated cells (p < 0.001) in a concentration-dependent manner was observed in the tryphan 
blue exclusion assay and in the Live/Dead® viability assay. Using APO-BrdU TUNEL assay, 
apoptotic activities of the extracts increased in a concentration-dependent manner. All the extracts 
did not show significant cytotoxic effect on hFSE cells (p = 0.064). 
Conclusion:  The cytotoxic and apoptotic activities of FP extracts may be due to the presence of 
lupeol and quercetin. This study suggests that apoptotic mechanisms may be involved in the growth 
inhibitory activity of FP leaf extracts against human PRST 2 cell lines.   
Keywords: Ficus pseudopalma, Cytotoxicity, Apopotic, human prostate PRST2 cancer cell, Lupeol, 
Quercetin. 
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Cancer is the second leading cause of mortality 
in the Philippines [1]. Next to lung carcinomas, 
prostate cancer is the most common malignancy 
in Filipino men with an estimated occurrence of 
19 out of every 100,000 Filipinos [2]. Like other 
cancer types, the pathogenesis of carcinomas 
involves the deregulation of multiple signaling 
pathways. Chemotherapy of carcinomas often 
involves the use of synthetic and/or natural 
products that control deregulated cell signaling 
pathways. While there are several plant-derived 
drugs in clinical use for the treatment of cancer, 
the discovery of new chemotherapeutic drugs 
that may regulate multiple cellular signaling 
pathways in a highly specific and sensitive 
Llagas et al 
Trop J Pharm Res, January 2014; 13(1): 94  
 
manner to control cancer cell growth, 
proliferation and apoptosis, is still needed.  
 
Ficus pseudopalma (FP) Blanco (Moraceae) is 
an endemic medicinal and ornamental tree found 
throughout the Philippines. The use of fig leaves 
for the treatment of kidney stones and diabetes 
in folkloric medicine [3] has been recently 
validated in a study where the anti-urolithiatic 
and antioxidant properties of the leaves of the 
plant were demonstrated by promoting free 
radical scavenging activity, inhibition of lipid 
peroxidation, and reduction of calcium oxalate 
crystal deposit in renal tissues [4].  
Phytochemical screening of air-dried leaves of  
FP  revealed the presence of ursenone and 
lupeol [5]. 
 
Ursonic acid has cytotoxic activities against 
cancer cell lines [6]. It has been postulated that 
lupeol may be a potential agent against prostate 
cancer through growth inhibition of tumors, cell 
cycle arrest, and induction of apoptosis [7]. 
 
Bioassay studies on the chemopreventive 
properties of FP has been limited to the cytotoxic 
effect of its ethanol extract on HepG2 [8]. In this 
study, we investigated the cytotoxic, 
antiproliferative, and apoptotic activities of FP 




Herbal material and extraction 
 
The mature leaves of F. pseudopalma Blanco 
were collected on May 22, 2012 from Umali 
Subd., Los Baňos, Laguna, Philippines. The 
plant was authenticated by Mr. Noe Gapas of the 
Philippine National Museum, Manila, Philippines. 
Voucher specimen no. 2013.001.001 was kept in 
the AdDU Herbarium, Ateneo de Davao 
University for future reference. The leaves were 
air-dried at room temperature, pulverized using 
Wiley Mill grinder, and sieved in a 22 mm wire 
mesh. Approximately 2.5 kilograms of air-dried 
leaves were completely submerged and 
extracted twice with 12.5 L of 95 % ethanol 
(technical grade) at room temperature for 48 
hours and evaporated to dryness by reduced-
pressure at 40 °C in a rotary evaporator 
(Heidolph WB 2000) to yield the concentrated 
crude ethanolic (CE) extract. Fifty  grams of CE 
extract was dissolved in 500 mL distilled water 
and successively partitioned to exhaustion with 
chloroform (CF) and ethyl acetate (EF). The 
remaining water soluble fraction was designated 
as WF. The resulting fractions were evaporated 
to dryness by reduced-pressure evaporation at 
40 °C in a rotary evaporator (Heidolph WB 
2000).The extracts were stored in tightly-sealed 
amber tubes at 0 – 5 °C [9]. 
 
Salkowski’s test for terpenoid 
 
To their assigned test tubes, 1 mL of the CE, CF, 
EF, and WF was added with 1 mL of chloroform. 
Then, about 1 mL of concentrated sulphuric acid 
was introduced gently on the test tube wall. A 
reddish brown coloration of the interface 
indicates the presence of terpenoid.  Lupeol was 
used for positive control [10]. 
 
High performance liquid chromatography 
(HPLC) 
 
The fractions which confirmed the presence of 
terpenoids were further screened for the 
presence of lupeol by HPLC (Agilent 1200 
Series, Quarternary HPLC System). One mg of 
the compound was diluted with 5 mL methanol, 
and 10 µL of test solution was injected to a C18 
column  (150 x 4.6, 5 μm) as stationary phase 
with a mobile phase comprising methanol : 
acetonitrile (30:70 v/v). The sample was run at a 
flow rate of 1.0 mL/min and UV detection at 
210nm with a run time of 12.0 min [11]. The 
fractions were also screened for the presence of 
quercetin by HPLC. One mg of the compound 
was diluted with 5 mL methanol. For quercetin, 
10 μL of test solution was injected to a C18 
column (150 x 4.6, 5 μm). The mobile phase was 
methanol : acetonitrile : water (60:20:20 v/v/v). 
Flow rate was 1.1 mL / min and UV detection at 
262 nm. [12]. A standard curve of the different 
concentrations of lupeol and quercetin at 5, 25, 
50 and 100 ppm were prepared. The 
concentration of lupeol and quercetin in the 




The strain of human prostate PRST2 cancer cell 
lines was kindly provided by Dr. Samuel Bernal 
(GlobeTek Professionals, Incorporated). Non-
cancerous (healthy) human foreskin surface 
epithelial cells hFSE were also used in the study. 
All cells were routinely maintained at 37 °C in a 5 
% CO2-enriched humidified air atmosphere as 
monolayer cultures in 25 cm2 plastic Corning 
flasks (T-25) in RPMI-1640 (Gibco, USA) 
containing 10 % fetal bovine serum (FBS). 
Confluent were harvested with 0.05% trypsin–
EDTA (GIBCO, USA). The trypsin was 
neutralized by addition of RPMI-1640 
supplemented with 10 % FBS (1:1).  One mL of 
this suspension  was diluted in 4 mL of RPMI-
1640 with 10 % FBS  into new flasks every five 
days. 
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Serum-free RPMI-1640 (GIBCO, USA) was used 
to dilute the human cell lines to a concentration 
of 5 × 106 cells mL-. From this cell suspension, 
100 μL was pipetted into designated wells of the 
96-well microtiter plate, except for the three wells 
that contained only the culture medium and 
served as the blank control group. The plate was 
incubated for 24 h in a 5% CO2 incubator at 
37°C. After incubation, the spent culture medium 
was discarded and 100µL of serum-free culture 
medium containing the plant extracts at different 
concentrations ranging from 25 to 500 µg/mL 
were distributed into designated wells in 
triplicates. Paclitaxel (10 µg/mL, Sigma, USA) 
was used as positive control. The plate was 
incubated in a 5 % CO2 incubator at 37°C for 48 
h. Then, 20 μL of MTT reagent was added into 
each well. This plate was further incubated for 4 
h in CO2 incubator at 37 °C until dye was visible. 
Subsequently, the supernatant was discarded 
and 100 μL of DMSO was added unto each well. 
The absorbance was read with the Microplate 
ELISA reader (Corona Microplate Reader SH-
1000, Hitachi) at 540 nm. Growth inhibition (GI, 
%) was computed as in Eq 1. 
 
 GI (%) = 1 – {(As – Ab)/(Ac – Ab)}100 …….. (1) 
 
where As, Ab and Ac are the absorbance of 
sample, blank and negative control, respectively.  
The medium lethal concentration (IC50) for each 
extract was determined by interpolation of the 
graph on mortality percentages versus the 
concentration of the extracts through linear 
regression analysis. This was performed in 
triplicate with three independent experiments. 
 
Tryphan blue exclusion assay 
 
PRST2 cells grown to 80 % confluence on 12-
well plates were treated with different 
concentrations of CE, CF, EF, and WF extracts 
for 48 hours. Treated cells were trypsinized, 
pelleted, and resuspended in PBS. The viability 
of cells was determined by staining with an equal 
volume of 0.08 % tryphan blue (Invitrogen). This 
preparation was transferred on to the edge of the 
hemocytometer until suspension spreads through 
capillary action. The cells were counted within 
the 1 mm area of the hemocytometer under the 
low power objective of compound microscope. 
Cells stained blue were counted as dead cells, 
while unstained cells were counted as viable 
cells. Percent cell viability was calculated by 
dividing the total viable cells with total cells 
(viable and dead cells), and then multiplying this 
result with 100.  
 
Live/dead viability assay 
 
Briefly, PRST2 cells grown to 80% confluence on 
6 mm coverslips, were treated with different 
concentrations of CE and CF extracts for 48 
hours, followed by incubation with 40 µL of 
combined LIVE/DEAD® assay reagents 
(Molecular Probes, Invitrogen) for 30 - 45 min at 
room temperature protected from light. The cells 
exposed to UV for 30 min served as positive 
control. Fluorescence images were captured with 
Delta Vision System and analyzed using 
softwoRX software. 
 
Apoptosis assay  
 
PRST2 cells grown to 80 % confluence on 12-
well plates were treated with different 
concentrations of CE, CF, EF and WF extracts 
for 48 h. The treated cells were trypsinized, 
pelleted, and re-suspended in 500 µL of PBS. 
The cells were fixed with 1 mL of 4 %w/v 
paraformaldehyde in PBS on ice for 15 min. Cells 
were transferred into a centrifuge tube and 
centrifuged for 5 min at 300 x g. The supernatant 
was discarded by aspiration. Cells were washed 
twice in 5 mL PBS, and were pelleted through 
centrifugation. Cells were re-suspended in 500 
µL of PBS and 2 mL of ice-cold 70% ethanol and 
kept in a -20 °C freezer overnight. After fixation, 
the cells were washed and incubated in 50 µL 
DNA-labeling solution for 60 min at 37 °C.  The 
cells were then rinsed with 1 mL of rinse buffer 
and centrifuged at 300 x g. The supernatant was 
removed by aspiration. The cell pellet was 
resuspended in 100µL of Alexa Fluor 488-
conjugated anti-BrdU antibody solution for 30 
min at room temperature in the dark. Few drops 
of cells were deposited on a glass slide and 
counterstained with propidium iodide for another 
30 min in the dark. The cells were observed 




Results of the study were based on three 
independent experiments that were performed in 
triplicate. Data was expressed as mean ± 
standard error of mean (SEM). Four-parameter 
logistic regression analysis was used to 
determine the medium Inhibitory Concentration 
(IC50) of the extracts. The data were analyzed 
using two-way ANOVA followed by Tukey post-
hoc test for multiple comparisons. P < 0.05 was 
set to be the limit of significance. Statistical 
analyses were carried out using GraphPad 
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FP extracts contain triterpenoids and 
quercetin 
 
From the 2.5 kilograms of dried mature FP 
leaves used during extraction, the yield CE was 
3.48 %w/w. The percentage yields of the 
fractionated extracts were 37.55, CF, 3.89 EF, 
and 39.64 % WF. 
 
The presence of terpenoids were detected 
through Salkowsky’s test in CE, CF, and EF. 
Lupeol and quercetin were quantitatively 
determined by HPLC method whereby good 
linearity was achieved in the range 25-150 ppm. 
The regression equations and correlation 
coefficient for the reference were
8.458*35.10  , r2  = 0.9916 for lupeol 
and 8.476*72.87  , r2 = 0.9898 for 
quercetin. The concentration of lupeol in CE, CF, 
and EF were found to be 1591.74 ppm, 1170.76 
ppm and 5237.26 ppm, respectively. 
Furthermore, HPLC chromatogram revealed CE 
and CF to contain peak nearest to the standard 
quercetin with a concentration of 355.01 ppm 
and 457.50 ppm, respectively (Figure1).  
 
FP extracts induced changes in PRST2 cell 
ultrastructure 
 
Microscopic analysis of control untreated PRST2 
cells showed regular polygonal cells with short 
extensions and few rounded cells. In contrast, 
cells treated with CE and CF showed changes 
such as rounding of cells, loss of cell adhesion, 
sporadic distribution and decrease in cell density 
in a concentration-dependent manner.  
 
FP extracts inhibited proliferation of PRST2 
cells but not in hFSE 
 
 MTT cytotoxicity results showed that chloroform 
(CF) and ethylacetate (EF) fractions have the 
highest inhibitory activities followed by crude 
ethanol (CE) extract in a concentration-
dependent manner (Fig 2A). On the other hand, 
water fraction (WF) exhibited low inhibitory 
activities against PRST2 cells (Fig 2A). The 
median inhibitory concentration (IC50) values 
were estimated to be 4.16 µg/mL, 4.83 µg/mL, 
44.53 µg/mL and 708.1 µg/mL for EF, CF, CE 
and WF, respectively. Tukey’s HSD post hoc 
analysis indicated that there is no significant 
difference in the growth inhibitory activities of EF 
and CF (p = 0.691) against PRST2 cells but both 
have significantly greater inhibitory activities 
compared to CE (p = 0.038) and WF (p < 0.001).  
There is also a significant difference in the mean  
 
Figure 1: HPLC chromatograms of FP extracts and 
standards lupeol and quercetin. Ten µL of extracts CE, 
CF, and EF as well as standards lupeol and quercetin 
were injected to a C18 column as standard phase. 
Mobile phase consist of methanol:acetonitrile (30:70  
v/v) and methanol:acetonitrile:water (60:20:20 v/v/v) 
for lupeol and quercetin, respectively. UV detection at 
210 nm and 262 nm for lupeol and quercetin, 
respectively. (A-D). Chromatograms for detecting the 
presence of lupeol.  (A) Chromatogram of standard 
lupeol, (B) CE, (C) CF, and (D) EF. (E-H) 
Chromatograms for quercetin.  (E)Standard quercetin, 
(F)CE, (G)CF, and (H)EF. Results revealed the 
ethylacetate fraction to contain the peak nearest to the 
standard lupeol, while CE had the peak nearest to the 
standard quercetin. HPLC= high performance liquid 
chromatography,  CE = crude ethanol extract, 
CF=chloroform fraction, and EF= ethylacetate fraction. 
 
percentage inhibition of the seven concentrations 
(p < 0.001), in which Tukey’s HSD post hoc 
analysis indicated that the 25 µg/mL has 
significantly the least mean percentage inhibition. 
The 50 and 100 µg/mL do not differ (p = 0.770) 
but has significantly higher mean percentage 
inhibition as compared to the 25 µg/mL (p < 
0.001). The 200, 300, 400 and 500 do not differ 
(p = 0.436) but are significantly higher as 
compared to the other concentrations (all p-
values <0.05). However, the PaclitaxelTM positive 
control has the highest mean percentage 
inhibition (p < 0.05) as compared to the other 
concentrations (Figure 2A). The four extracts 
have no significant inhibitory activity against non-
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cancerous normal hFSE cells (p = 0.064) (Figure 
2B). 
 
Figure 2: Growth inhibition of FP extracts on PRST2 
cells and normal hFSE cells. Cells were seeded at 5 x 
10 6 cells/well and were treated with different 
concentrations of FP extracts, and growth inhibition 
(%) was determined by MTT assay 48 h post-
treatment. Results are mean values ± SEM of three 
independent experiments performed in triplicate with * 
p < 0.05. (A) Growth inhibition of FP on PRST2 cells. 
Data show a concentration-dependent inhibition was 
observed at concentrations ranging from 25 to 500 
µg/mL for PRST2-treated cells. The effects of CE,CF, 
and EF are significantly different from the untreated 
control and 1% DMSO control, but is not significantly 
different from the positive Paclitaxel control. (B) 
Growth inhibition of FP on normal human Foreskin 
surface epithelial cells. Results did not show any 
significant effect of FP extracts on the cell viability of 
hFSE. CE = crude ethanol extract, CF=chloroform 
fraction, EF= ethylacetate fraction, WF= water fraction, 
and (+)C=positive control. 
 
FP extracts decreased the viability of PRST2 
cells 
 
There was a significant difference in the mean 
percentage cell viability of the four extracts (p < 
0.001), in which Tukey’s HSD post hoc analysis 
indicated that CF exerted the least mean 
percentage viability, while the WF did not differ 
significantly with 1 % DMSO control and negative 
control (p = 0.247). Furthermore, the positive 
control did not differ (p = 0.555) with CE, CF, and 
EF. The effect of CE, CF, and EF extracts 
exerted a concentration dependent decrease in 
the viability of PRST2 cells (Figure 3).  
 
 
Figure 3: Viability (%) of PRST2 cells 48 h post-
treatment with different concentrations of Ficus 
pseudopalma extracts. Cells were subjected to the 
Tryphan blue exclusion assay. Note that water fraction 
and 1% DMSO do not differ significantly with the 
untreated PRST2 control (p = 0.247). Beginning with 
50µg/mL, CE, CF, and EF significantly decreased the 
viability of PRST2 cells compared to untreated control 
(*p < 0.05), while WF is significantly different 
beginning at 300 µg/mL. However, the positive control 
do not differ significantly with extracts CE, CF, and EF 
at the concentrations ranging from 50 to 500 µg/mL (p 
= 0.247). CE = crude ethanol extract, CF = chloroform 
fraction, EF = ethylacetate fraction, and WF = water 
fraction. 
 
The effects of CE and CF at 100 µg / mL and 300 
µg/mL on cell viability were further confirmed by 
two-color fluorescence LIVE/DEAD® Assay that 
measures the intracellular esterase activity and 
plasma membrane integrity of cells. The green 
fluorescence intensity observed in PRST2 cells 
were lower in the cells treated with 300 µg/mL 
and 100 µg/mL of CE and CF compared to 
untreated controls. In contrast, the red 
fluorescence intensity observed in PRST2 cells 
were higher in the cells treated with 300 µg/mL 
and 100 µg/mL of CE and CF compared to 
untreated controls (Figure 4).   
 
FP extracts induced apoptosis in PRST2 cells 
 
The apoptotic activity of FP extracts on PRST2 
cells are shown in Figure 5. There was an 
increase in the number of apoptotic-labeled cells 




The chemo-preventive activity of Ficus species 
against renal carcinogenesis, human glioma and 
human hepatocellular carcinoma, HeLa cells, 
breast cancer cells, human nasopharyngeal 
carcinoma, oral epidermoid carcinoma KB and 
colorectal HT29 cancer cell lines have been 
reported [6,14-17]. However, the study on the 
chemo-preventive property of the endemic 
Philippine tree Ficus pseudopalma (FP) has 
been limited to its effect on hepatocellular 
carcinoma HepG2 cell [8]. Results from this 
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study confirms that the crude ethanolic extract, 
chloroform fraction and ethylacetate fractions 
prepared from the leaves of FP have strong 
concentration-dependent growth inhibitory 
activity against PRST2 cells and low cytotoxicity 
against non-cancerous hFSE cells (Fig 2). Our 
results show that CE has greater cytotoxicity 
against prostate cancer (IC50 of 44.53 µg/mL), 
compared to HepG2 cells (IC50 = 300 µg/mL) [8]. 
 
Figure 4: Micrographs of PRST2 cells 48 hours post-
treatment with different concentrations of Ficus 
pseudopalma extracts. Cells were subjected to the 
LIVE/DEAD Cell Viability/Cytotoxicity Assay 
(Invitrogen).  Green fluorescence (λem = 490 nm) 
show live cells while red fluorescence (λem = 555 nm) 
show dead cells. Note the increasing number of dead 
cells as the concentration of the extract increases. CE 
= crude ethanol extract and CF = chloroform fraction; 
scale bars represent 90µm. Magnification: 40x. 
 
Visible cytotoxic effects of CE and CF shown in 
the microscopic analysis of treated PRST2 cells 
revealed changes in cell shape from polygonal to 
round cells, loss of adherence which is 
characteristic of dying or dead cells, increase in 
cellular debris, and decrease in cell density. A 
decrease in green fluorescence and increase in 
red fluoresce in the LIVE/DEAD® Assay as the 
concentration of CE and CF extract increases 
reinforces the concentration-dependent effect of 
the extracts on PRST2 cells due to increasing 
concentration of phytochemicals that have 
growth inhibitory activities and/or have disruptive 
effects on cell membrane integrity. In living cells, 
non-fluorescent calcein AM is enzymatically 
converted by ubiquitous intracellular esterase 
activity into a brightly green fluorescent calcein 
(excitation/emission at 495/515 nm). On the 
otherhand, ethidium homodimer 1 (which is 
excluded from live cells with intact cell 
membranes) gives-off red fluorescence once 
intercalated into the nucleus of dead cells 




Figure 5: Micrographs of apoptotic PRST2 cells 48 
hours post-treatment with different concentrations of 
Ficus pseudopalma extracts. Cells were subjected to 
the APO-BrDU TUNEL assay (Invitrogen).  Green 
fluorescence (λem = 490 nm) show apoptotic cells 
while red fluorescence (λem = 555 nm) show necrotic 
cells. Note the increasing number of apoptotic cells as 
the concentration of the extract increases. (A) 
Untreated PRST2 cells, (B) Positive control from 
TUNEL kit, (C) (D) treated with 100 and 300 µg/mL of 
CE, and (E) (F) treated with 100 and 300 µg/mL of CF. 
CE=crude ethanol and CF = chloroform fraction. 
Magnification: 40X 
 
The anticancer activity of Ficus species have 
been attributed to its naturally occurring 
compounds such as terpenoids and flavonoids 
that may prevent oxidative stress-related 
diseases like cancer [18]. Earlier studies have 
confirmed the presence of the triterpenoid lupeol 
in FP leaves [4-5], as well as its antioxidant 
properties [4] [8]. In this study, phytochemical 
screenings of the extracts lead to the 
identification of compounds such as lupeol and 
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quercetin which may be responsible for its 
cytotoxic activity. The anticancer property of 
lupeol, a dietary triterpene found in certain fruits, 
vegetables, and medicinal plants, has been 
demonstrated by its ability to suppress the 
growth of hepatocellular carcinoma and 
melanoma cell lines [19]. A decrease in prostate-
specific antigen secretion in athymic nude mice 
implanted with CWR22Rnu1 cells after treatment 
with lupeol, as well as inhibition of tumor growth 
suggest that lupeol may have a potential to be an 
effective agent against prostate cancer [17].  
A previous study showed that the dry roots of 
Ficus hirta Vahl inhibited the growth of HeLa cells 
through induction of apoptosis [16]. In this study, 
a concentration-dependent increase in apoptotic 
PRST2-treated cells as shown by the 
incorporation of BrdU was observed 48 hours 
post-treatment with CE and CF extracts. The 
flavonol quercetin has been reported to induce 
apoptosis in HepG2 cells and MCF-7 cells [20], 
while lupeol is known to induce G2/M cell cycle 
arrest by modulating microtubule assembly 
followed by apoptotic death of prostate cancer 
cells [7].  
 
The increase in the concentration of lupeol as the 
concentration of the extract was increased may 
account for the concentration-dependent 
cytotoxic and apoptotic activities of CE, CF, and 
EF extracts. In another study, lupeol induced 
apoptosis through Fas-receptor mediated 
pathway in a dose-dependent mechanism [7]. In 
addition, high concentrations of quercetin were 
found to have cytotoxic activity against MCF-7 
cells [21]. 
FP was found to have little inhibitory activity 
against non-cancerous hFSE cells. In another 
study, FP ethanolic extracts enhanced the 
proliferation of normal non-cancerous Peripheral 
Blood Mononuclear Cells (PBMC) [8]. This 
indicates the protective effect of FP extracts on 





The present study established the cytotoxic and 
apoptotic activities of FP extracts against PRST2 
cells while having no adverse effect on normal 
hFSE cells. This study also provided evidence on 
the pharmaceutical potential of Ficus 
pseudopalma Blanco leaves as a 
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